Literature DB >> 19760052

Prevention of inappropriate ICD shocks in patients with Brugada syndrome.

Christian Veltmann1, Juergen Kuschyk, Rainer Schimpf, Florian Streitner, Nina Schoene, Martin Borggrefe, Christian Wolpert.   

Abstract

BACKGROUND: In Brugada syndrome implantable cardioverter defibrillator (ICD) therapy is associated with a high rate of inappropriate therapies, mainly due to supraventricular tachyarrhythmias (SVT) (2.7-14.1%/year). Aim of the present study was to evaluate a single ventricular fibrillation (VF) detection zone with a high cut-off rate with respect to prevention of inappropriate ICD shock due to SVT and safety of this programming.
METHODS: Sixty-one consecutive patients (mean age 42.6 +/- 12.9 years; 41 males) diagnosed with Brugada syndrome and implanted with an ICD were included. ICDs were prospectively programmed with a single VF detection zone and a cut-off rate of 222 beats/minute (bpm). A maximum of six shocks with the maximal shock energy were programmed. The minimal follow-up was 1 year.
RESULTS: During a follow-up of 47.6 +/- 23.1 months seven patients (2.91%/year) received appropriate ICD shocks. No patient suffered from syncope or died. Five patients (2.07%/year) received inappropriate ICD shocks: four patients due to T-wave oversensing and only one patient (0.4%/year) due to SVT (atrial fibrillation with a ventricular rate of >222 bpm).
CONCLUSIONS: Programming of a single, high-rate VF zone in patients with Brugada syndrome and an implanted defibrillator is safe. Such programming may be associated with reduced inappropriate defibrillator discharges. A single detection zone with a high VF cut-off rate can be recommended in patients with Brugada syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19760052     DOI: 10.1007/s00392-009-0075-4

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  32 in total

1.  Monomorphic ventricular tachycardia due to Brugada syndrome successfully treated by hydroquinidine therapy in a 3-year-old child.

Authors:  Vincent Probst; Stephane Evain; Veronique Gournay; Allouis Marie; Jean-Jacques Schott; Pierre Boisseau; Herve LE Marec
Journal:  J Cardiovasc Electrophysiol       Date:  2006-01

2.  When life-saving devices terminate life.

Authors:  Andrei Catanchin; Lisa Anderson; Sue Jones; David Ward
Journal:  J Cardiovasc Electrophysiol       Date:  2008-02-04

3.  Case report: inappropriate discharge of an implantable cardioverter-defibrillator caused by the combined count criterion.

Authors:  C Wolpert; W Jung; S Spehl; T Korte; B Lüderitz
Journal:  J Interv Card Electrophysiol       Date:  1998-03       Impact factor: 1.900

4.  Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.

Authors:  Peter Alter; Stefan Waldhans; Eveline Plachta; Rainer Moosdorf; Wolfram Grimm
Journal:  Pacing Clin Electrophysiol       Date:  2005-09       Impact factor: 1.976

Review 5.  Brugada syndrome: report of the second consensus conference.

Authors:  Charles Antzelevitch; Pedro Brugada; Martin Borggrefe; Josep Brugada; Ramon Brugada; Domenico Corrado; Ihor Gussak; Herve LeMarec; Koonlawee Nademanee; Andres Ricardo Perez Riera; Wataru Shimizu; Eric Schulze-Bahr; Hanno Tan; Arthur Wilde
Journal:  Heart Rhythm       Date:  2005-04       Impact factor: 6.343

6.  Monomorphic ventricular tachycardia in 'Brugada syndrome': clinical case and literature review.

Authors:  Giuseppe Allocca; Alessandro Proclemer; Gaetano Nucifora; Erica Dall'Armellina; Luca Rebellato
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2008-08       Impact factor: 2.160

7.  Prevalence of supraventricular tachyarrhythmias in a cohort of 115 patients with Brugada syndrome.

Authors:  Rainer Schimpf; Carla Giustetto; Lars Eckardt; Christian Veltmann; Christian Wolpert; Fiorenzo Gaita; Günter Breithardt; Martin Borggrefe
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-07       Impact factor: 1.468

8.  "Home monitoring" for early detection of implantable cardioverter-defibrillator failure: a single-center prospective observational study.

Authors:  Melanie Hauck; Alexander Bauer; Frederik Voss; Slawomir Weretka; Hugo A Katus; Ruediger Becker
Journal:  Clin Res Cardiol       Date:  2008-09-05       Impact factor: 5.460

9.  Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome.

Authors:  Hiroshi Morita; Kengo Kusano-Fukushima; Satoshi Nagase; Yoshihisa Fujimoto; Kenichi Hisamatsu; Hideki Fujio; Kayo Haraoka; Makoto Kobayashi; Shiho Takenaka Morita; Kazufumi Nakamura; Tetsuro Emori; Hiromi Matsubara; Kazumasa Hina; Toshimasa Kita; Masahiko Fukatani; Tohru Ohe
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

10.  Natural history of Brugada syndrome: insights for risk stratification and management.

Authors:  Silvia G Priori; Carlo Napolitano; Maurizio Gasparini; Carlo Pappone; Paolo Della Bella; Umberto Giordano; Raffaella Bloise; Carla Giustetto; Roberto De Nardis; Massimiliano Grillo; Elena Ronchetti; Giovanna Faggiano; Janni Nastoli
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

View more
  17 in total

Review 1.  The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Authors:  Johannes Steinfurt; Jürgen Biermann; Christoph Bode; Katja E Odening
Journal:  Dtsch Arztebl Int       Date:  2015-06-05       Impact factor: 5.594

Review 2.  [Primary and secondary prophylactic ICD therapy in congenital electrical and structural cardiomyopathies].

Authors:  D Duncker; T König; S Hohmann; C Veltmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-05-22

3.  Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine.

Authors:  Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal:  Clin Res Cardiol       Date:  2010-03-11       Impact factor: 5.460

4.  [Ion channel diseases in children].

Authors:  Christian Wolpert; Ulli Parade; Claudia Herrera-Siklody; Christian Strotmann; Norman Rüb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-08-23

Review 5.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update.

Authors:  A Azaouagh; S Churzidse; T Konorza; R Erbel
Journal:  Clin Res Cardiol       Date:  2011-03-01       Impact factor: 5.460

6.  Sudden cardiac death in the young: how can disease recognition and prevention in family members be improved?

Authors:  Rainer Schimpf; Katrin Yen; Martin Borggrefe
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-09

Review 7.  [Brugada syndrome].

Authors:  Christian Veltmann; Hanno Oswald; Johann Bauersachs
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-09-20

Review 8.  Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease.

Authors:  Ardan M Saguner; Corinna Brunckhorst; Firat Duru
Journal:  World J Cardiol       Date:  2014-04-26

Review 9.  [Syncopes and channelopathies].

Authors:  Johanna Müller-Leisse; Christos Zormpas; Thorben König; David Duncker; Christian Veltmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-05-15

10.  Atrial fibrillation in cardiac channelopathies.

Authors:  Jayachandran Thejus; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2009-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.